Public filings / ADPT on Yahoo Finance (opens in a new tab)
ADPT: insider buying, 13F holders, analyst moves
Adaptive Biotechnologies Cor
A summary of public filings about Adaptive Biotechnologies Cor. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
4 of our 100 managers hold ADPT
Combined reported value $683.3M; 1 sold out since Q1 2026.
Holders among our 100 managers: 1 in Q3 2023, 4 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| Viking Global Investors | $643.4M | 1.83% | Unchanged |
| Perceptive Advisors | $26.1M | 0.40% | Added |
| Tudor Investment | $11.7M | 0.05% | Trimmed |
| Polen Capital | $2.2M | 0.02% | Trimmed |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.